This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
. Page versions: R5 R4B R4 R3
| Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Patient, Practitioner |
Raw JSON (canonical form + also see JSON Format Specification)
Dispense for Brentuximab Vedotin (NDC code) - IV Chemo - stopped
{
"resourceType": "MedicationDispense",
"id": "meddisp0317",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>status</b>: stopped</p><p><b>medication</b>: <a> </a></p><blockquote><p><b>code</b>: <span>Adcetris (Brentuximab Vedotin 50mg/10.5ml)</span></p><p><b>manufacturer</b>: <a>Generated Summary: active; name: Acme Corporation</a></p><p><b>form</b>: <span>Lyophilized powder for injectable solution (qualifier value) </span></p></blockquote><p><b>subject</b>: <a>Donald Duck . Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male</a></p><h3>Performers</h3><table><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a>Generated Summary: id: 937223645 (OFFICIAL), id: 134IDY41W988 (USUAL); Rob van den Berk (OFFICIAL); Phone: 0205569288, R.A.vandenberk@bmc.nl, Fax: 0205664987; gender: male; birthDate: 1975-12-07</a></td></tr></table><p><b>authorizingPrescription</b>: <a>Generated Summary: id: 12345689 (OFFICIAL); status: completed; intent: order; ?ngen-3; authoredOn: 2015-01-15; instantiatesUri: http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf</a></p><p><b>type</b>: <span>Trial Fill</span></p><p><b>quantity</b>: 3 415818005</p><p><b>daysSupply</b>: 1 Day</p><p><b>whenPrepared</b>: 25 Jun. 2015, 12:13:00 pm</p><p><b>whenHandedOver</b>: 26 Jun. 2015, 12:13:00 pm</p><h3>DosageInstructions</h3><table><tr><td>-</td></tr><tr><td>*</td></tr></table></div>"
},
"contained": [
{
"resourceType": "Medication",
"id": "med0306",
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/sid/ndc",
"code": "51144-050-01",
"display": "Adcetris (Brentuximab Vedotin 50mg/10.5ml)"
}
]
},
"manufacturer": {
"reference": "Organization/mmanu"
},
"form": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "421637006",
"display": "Lyophilized powder for injectable solution (qualifier value) "
}
]
}
}
],
"status": "stopped",
"medicationReference": {
"reference": "#med0306",
"display": "Brentixumab Vedotin (Adcetris)"
},
"subject": {
"reference": "Patient/pat1",
"display": "Donald Duck "
},
"performer": [
{
"actor": {
"reference": "Practitioner/f006"
}
}
],
"authorizingPrescription": [
{
"reference": "MedicationRequest/medrx0316"
}
],
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
"code": "TF",
"display": "Trial Fill"
}
]
},
"quantity": {
"value": 3,
"system": "http://snomed.info/sct",
"code": "415818005"
},
"daysSupply": {
"value": 1,
"unit": "Day",
"system": "http://unitsofmeasure.org",
"code": "d"
},
"whenPrepared": "2015-06-25T07:13:00+05:00",
"whenHandedOver": "2015-06-26T07:13:00+05:00",
"dosageInstruction": [
{
"sequence": 1,
"text": "1.8 mg/kg IV infusion over 30 minutes every 3 weeks for 16 cycles",
"timing": {
"repeat": {
"count": 16,
"frequency": 1,
"period": 3,
"periodUnit": "wk"
}
},
"route": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "255560000",
"display": "Intravenous"
}
]
},
"doseAndRate": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/dose-rate-type",
"code": "ordered",
"display": "Ordered"
}
]
},
"doseQuantity": {
"value": 1.8,
"unit": "mg/kg",
"system": "http://unitsofmeasure.org",
"code": "mg/kg"
}
}
]
}
]
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.